An analysis of the U.S. Environmental Protection Agency neurotoxicity testing guidelines

NeurotoxKb 1.0: Compilation, curation and exploration of a knowledgebase of environmental neurotoxicants specific to mammals

Exposure to environmental neurotoxicants is a significant concern due to their potential to cause permanent or irreversible damage to the human nervous system. Here, we present the first dedicated knowledgebase, NeurotoxKb 1.0, on environmental neurotoxicants specific to mammals. Using a detailed workflow, we have compiled 475 potential non-biogenic neurotoxicants from 835 published studies with evidence of neurotoxicity specific to mammals. A unique feature of NeurotoxKb 1.0 is the manual curation effort to compile and standardize the observed neurotoxic effects for the potential neurotoxicants from 835 published studies. For the 475 potential neurotoxicants, we have compiled diverse information such as chemical structures, environmental sources, chemical classification, physicochemical properties, molecular descriptors, predicted ADMET properties, and target human genes. To better understand the prospect of human exposure, we have explored the presence of potential neurotoxicants in external exposomes via two different analyses. By analyzing 55 chemical lists representing global regulations and guidelines, we reveal potential neurotoxicants both in regular use and produced in high volume. By analyzing human biospecimens, we reveal potential neurotoxicants detected in them. Lastly, a construction of the chemical similarity network and ensuing analysis revealed the diversity of the toxicological space of 475 potential neurotoxicants. NeurotoxKb 1.0 is accessible online at: https://cb.imsc.res.in/neurotoxkb/.

Effect of Single Versus Repeated Exposure to 1,1,1-Trichloroethane on Rat Operant Behavior

A design feature of most dose-response studies involving schedule-controlled operant behavior is the repeated administration of different doses of the test substance to the same experimental animal. Repeated dosing raises the question of whether or not an animal's initial exposure to a chemical agent alters its behavioral response to subsequent exposures. To address this question, a dose-response curve for the effect of inhaled 1,1,1-trichloroethane (TRI) on the rate of lever-pressing for milk delivery was generated with repeatedly exposed rats (i.e., a within-subject design) and compared to dose-response data obtained from rats receiving a single inhalation exposure to TRI (i.e., a between-group design). Relative to that generated with singly exposed rats, the dose-response curve generated by repeated exposure was shifted to the left. This suggests that the behavioral effects of rate-decreasing concentrations of TRI are augmented by previous exposures. This residual effect is apparently not due to the accumulation of pharmacologically active substances or to the development of an aversion to responding, since TRI is rapidly eliminated following exposure and solvent-free responding was unaffected 24 h postexposure. Instead, the results of this study support the well-established belief that an animal's response to a drug or chemical agent can be modified by its prior behavioral and exposure history. Thus, comparisons of single and repeated exposures may be necessary for fully accurate interpretations of the behavioral consequences of solvent exposure.

“Current Pathology Techniques” Symposium Review: Advances and Issues in Neuropathology

Our understanding of the mechanisms that incite neurological diseases has progressed rapidly in recent years, mainly owing to the advent of new research instruments and our increasingly facile ability to assemble large, complex data sets acquired across several disciplines into an integrated representation of neural function at the molecular, cellular, and systemic levels. This mini-review has been designed to communicate the principal technical advances and current issues of importance in neuropathology research today in the context of our traditional neuropathology practices. Specific topics briefly addressed in this paper include correlative biology of the many facets of the nervous system; conventional and novel methods for investigating neural structure and function; theoretical and technical issues associated with investigating neuropathology end points in emerging areas of concern (developmental neurotoxicity, neurodegenerative conditions); and challenges and opportunities that will face pathologists in this field in the foreseeable future. We have organized this information in a manner that we hope will be of interest not only to professionals with a career focus in neuropathology, but also to general pathologists who occasionally face neuropathology questions.

Neuroblastoma cell lines--a versatile in vitro model in neurobiology

Neuroblastoma (NB) cell lines are transformed, neural crest derived cells, capable of unlimited proliferation in vitro. These cell lines retain the ability of differentiation into neuronal cell types on treatment with various agents. This ability of NB cells to proliferate as well as to differentiate makes it an excellent in vitro system for various studies. This review article focuses on the applications and potential uses of murine and human NB cell lines. NB cells are extensively used for testing neurotoxicity of putative drugs such as antimalarial or anticancer agents. NB cell lines have wide applications in virus research to understand various aspects of virus-host cell interactions at the molecular and cellular levels. They have been used to dissect the relationships between proliferation, differentiation and apoptosis. This feature has been useful in understanding the pediatric cancer--neuroblastoma and for development of newer therapies.

Testing methods for developmental neurotoxicity of environmental chemicals

Human brain development is slow and delicate, involving many unique, though interrelated, cellular events. The fetus and child are often more susceptible to chemical toxins that alter the structure and/or function of the brain, although susceptibility varies for individual neurotoxicants. Early exposure to neurotoxins has been implicated in neurological diseases and mental retardation. Pesticide exposures pose a particular concern since many are designed to be neurotoxic to pests and can also affect humans. Acknowledging the potential for vulnerability of the developing brain, EPA recently began to "call in" data on developmental neurotoxicity (DNT) from manufacturers of pesticides already registered and considered to be neurotoxic-around 140 pesticides. Chemicals are to be tested following the DNT testing guideline (OPPTS 870.6300). This paper assesses whether tests performed according to this guideline can effectively identify developmental neurotoxicants. We found the testing guideline deficient in several respects, including: It is not always triggered appropriately within the current tiered system for testing; It does not expose developing animals during all critical periods of vulnerability; It does not assess effects that may become evident later in life; It does not include methodology for consideration of pharmacokinetic variables; Methodology for assessment of neurobehavioral, neuropathological, and morphometry is highly variable; Testing of neurochemical changes is limited and not always required. We propose modifications to the EPA testing guideline that would improve its adequacy for assessing and predicting risks to infants and children. This paper emphasizes that deficiencies in the testing methodology for developmental neurotoxicants represent a significant gap and increase the uncertainty in the establishment of safe levels of exposure to developing individuals.